Karyn Aalami Goodman was named associate director for clinical research at Mount Sinai’s The Tisch Cancer Institute. She is also professor and vice chair for research and quality in the Department of Radiation Oncology.
While doing somewhat-routine reporting on this year’s Senate Appropriations Committee bills, Paul Goldberg, editor and publisher of The Cancer Letter, quickly realized that he was seeing a full bipartisan rejection of President Donald J. Trump’s plan to defund and therefore dismantle biomedical research in the United States.
